Stephen Willard

Stephen Willard

Former Chief Executive OfficeratNRX Pharmaceuticals· In proxies 2023–2024

Pay in FY2024-21% from the year before · NRX Pharmaceuticals stock -52.2% the same year

Stephen Willard was paid $395.8K in FY2024 (Dec), down 21%. NRX Pharmaceuticals stock fell 52.2% that year.

Pay$100 in the stock at the end of FY22 → $20
Pay is from the Summary Compensation Table of each NRX Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NRX PharmaceuticalsPublic company · 3 yr
    • Former Chief Executive Officer2023 – Present · 3 yrStock in role -76%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?